More Articles

Teva with ratiopharm market leader in European generics Generics/News | Posted 26/03/2010

On 18 March 2010 Teva announced that it has entered into a definitive agreement to acquire ratiopharm, Germany's second largest generics producer and the sixth largest generic drug company worldwid...

South Korea to emerge as global leader in biosimilar R & D Biosimilars/News | Posted 26/03/2010

According to the South Korea Pharmaceuticals and Healthcare Report Q2 2010 released by Business Monitor International (BMI) in March 2010, South Korea will emerge as a global leader in biosimilar r...

Generic substitution of cyclosporin sometimes undesired Generics/General | Posted 26/03/2010

The bio-equivalence criteria of the Dutch Medicines Evaluation Board (CBG-MEB) offer insufficient guarantee for a safe substitution of generic medicines in transplantation medicine, argue Internist...

FDA adds Boxed Warning to clopidogrel label: drug less effective in poor metabolizers with CYP2C19 gene variant Generics/News | Posted 23/03/2010

Sanofi-aventis and Bristol-Myers Squibb announced on 12 March 2010 revisions to the US prescribing information for its anti-blood clotting drug Plavix (clopidogrel bisulfate).

AutekBio to build ‘Asia’s largest biologics contract manufacturing organisation’ in China Biosimilars/News | Posted 19/03/2010

AutekBio, Inc. –with headquarters in the Bay Area of California, USA, but operations in China– will build one of Asia’s largest biologic contract manufacturing organisation (CMO) facilities in sout...

AstraZeneca signs branded-generics deal with Torrent to boost emerging-markets presence Generics/News | Posted 18/03/2010

AstraZeneca announced on 11 March 2010 a license and supply agreement with Torrent Pharmaceuticals. Torrent will supply to AstraZeneca a portfolio of generic medicines for which Torrent already has...

India claims to be world leader in generics exports Generics/General | Posted 17/03/2010

The Indian government has said that India ranks top in the world in exporting generic medicines, with a worth of 50,000 billion rupees a year. The country is now exporting to more than 200 nations...

FDA warning letter to Chinese API supplier Xian Libang Pharmaceutical Generics/News | Posted 17/03/2010

The FDA has warned Xian Libang Pharmaceutical Co. Ltd, a maker of active pharmaceutical ingredients (APIs); because its quality control unit failed to detect that an employee had manipulated testin...